Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Citric Acid → Escitalopram
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Citric Acid | HCID 311 | — |
| 반응물 | Sucrose | HCID 5988 | — |
| 반응물 | Aspartame | HCID 134601 | — |
| 반응물 | Escitalopram Oxalate | HCID 146571 | — |
| 용매 | Glycerol | HCID 753 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Escitalopram | HCID 146570 | — |
반응 단계
The composition of the formulation and the amounts of the ingredients are shown in the table below. Citric acid was dissolved in 200 ml of distilled water and then sodium alginate (Protanal LF10/60, FMC Biopolymer), glycerol and sucrose were added and dissolved at 60° C. The obtained solution was cooled to ambient temperature and, then, Aspartame, Escitalopram Oxalate and Fantasy flavor were added and dissolved therein. The resulting solution was cast onto casting mold having casting area of 1,150 cm2 and dried according to Example 3.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08840935B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-e1b8f4cebdf942f3a50951d8c18284b7 |
| 출처 메모 | uspto-grants-2014_09 |